D&H Distributing has released a list of growth areas that the Harrisburg, Pennsylvania-based company believes will gain the most traction in the new year.
The distributor believes “Everything-as-a-Service” will fully emerge in 2019, and resellers will more frequently deliver hosted services to address business requirements, capitalizing on platforms such as Microsoft Office 365, Cisco Webex Teams, and Azure. The company believes this trend will encompass functions such as hosted printing, web-based services, collaboration, storage, and document management, on through larger capabilities like hosted email XChange and data center services.
Growth categories are led by Pro AV/digital signage, which saw 112% year-over-year growth, and cloud solutions with 108% growth. Other projected growth areas include unified communications/collaboration (55%), network security (41%), mobile workstations (41%), laser printers (39%), premium notebooks (31%), server/datacenter (26%), and wireless networking (19%).
D&H plans to expand its solutions portfolio in burgeoning areas such as pro AV, lifecycle management, and Device-as-a-Service. The distributor will also be working with major vendors in 2019 to address SMB infrastructure refresh opportunities for VARs, including education and resources around end-of-support deadlines, plus device- and cloud-based services that resellers can administer in the SMB space.
“We not only plan to identify areas of opportunity, we plan to invest in those categories by way of training and deep support,” said co-president Michael Schwab. “It’s our job to test the waters in areas like AR, DaaS, collaboration, the connected office, and the evolving world of cybersecurity. We arm customers with the tools they need to attack these markets, positioning themselves for growth.”
D&H Distributing has sustained 21% growth for the 2018 calendar year (through November, as per the latest available figures).
The announcement provides allied channel partners with guidance regarding planned investments by the distributor for 2019.